NO20021394L - Quetiapingranuler - Google Patents

Quetiapingranuler

Info

Publication number: NO20021394L
Authority: NO; Norway
Prior art keywords: quetiapingranuler
Prior art date: 1999-09-21

Application number

NO20021394A

Other languages

English (en)

Other versions

NO320908B1 (no

NO20021394D0 (no

Inventor

Daniel Boyd Brown

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-21

Filing date

2002-03-20

Publication date

2002-03-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10861288&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021394(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-03-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-03-20 Publication of NO20021394L publication Critical patent/NO20021394L/no

2002-03-20 Publication of NO20021394D0 publication Critical patent/NO20021394D0/no

2006-02-13 Publication of NO320908B1 publication Critical patent/NO320908B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

NO20021394A 1999-09-21 2002-03-20 Granulformulering, fremgangsmate til fremstilling derav, anvendelse derav for behandling av sykdommer, samt pose som inneholder formuleringen. NO320908B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9922271.3A GB9922271D0 (en)	1999-09-21	1999-09-21	Formulation
PCT/GB2000/003598 WO2001021179A1 (en)	1999-09-21	2000-09-18	Quetiapine granules

Publications (3)

Publication Number	Publication Date
NO20021394L true NO20021394L (no)	2002-03-20
NO20021394D0 NO20021394D0 (no)	2002-03-20
NO320908B1 NO320908B1 (no)	2006-02-13

Family

ID=10861288

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021394A NO320908B1 (no)	1999-09-21	2002-03-20	Granulformulering, fremgangsmate til fremstilling derav, anvendelse derav for behandling av sykdommer, samt pose som inneholder formuleringen.

Country Status (37)

Country	Link
US (3)	US6599897B1 (no)
EP (1)	EP1218009B1 (no)
JP (1)	JP2003509461A (no)
KR (1)	KR100748823B1 (no)
CN (3)	CN1188130C (no)
AR (1)	AR032596A1 (no)
AT (1)	ATE288272T1 (no)
AU (1)	AU776292B2 (no)
BG (1)	BG65469B1 (no)
BR (1)	BR0014107A (no)
CA (1)	CA2383131A1 (no)
CO (1)	CO5180585A1 (no)
CZ (1)	CZ301585B6 (no)
DE (1)	DE60017923T2 (no)
DK (1)	DK1218009T3 (no)
EE (1)	EE200200150A (no)
EG (1)	EG24226A (no)
ES (1)	ES2235941T3 (no)
GB (2)	GB9922271D0 (no)
HK (1)	HK1047706B (no)
HU (1)	HUP0203531A3 (no)
IL (2)	IL148440A0 (no)
IS (1)	IS2139B (no)
MX (1)	MXPA02002627A (no)
MY (1)	MY130208A (no)
NO (1)	NO320908B1 (no)
NZ (1)	NZ517549A (no)
PL (1)	PL198824B1 (no)
PT (1)	PT1218009E (no)
RU (1)	RU2256453C2 (no)
SI (1)	SI1218009T1 (no)
SK (1)	SK286884B6 (no)
TR (1)	TR200200716T2 (no)
TW (1)	TWI226832B (no)
UA (1)	UA73529C2 (no)
WO (1)	WO2001021179A1 (no)
ZA (1)	ZA200201709B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9922271D0 (en) *	1999-09-21	1999-11-17	Zeneca Ltd	Formulation
SE0102855D0 (sv) *	2001-08-27	2001-08-27	Astrazeneca Ab	Method of treatment
WO2003039516A1 (en) *	2001-11-07	2003-05-15	Fujisawa Pharmaceuticla Co., Ltd.	Method for improving dissolution of poorly dispersible medicaments
JP4514473B2 (ja) *	2004-02-23	2010-07-28	富士通株式会社	コンピュータシステム、中央装置及びプログラム実行方法
UA88792C2 (ru) *	2004-11-10	2009-11-25	Таргасепт, Інк.	Гидроксибензоатные соли метаникотиновых соединений
US7459469B2 (en)	2004-11-10	2008-12-02	Targacept, Inc.	Hydroxybenzoate salts of metanicotine compounds
AR053237A1 (es)	2005-04-21	2007-04-25	Medichem Sa	Proceso para la preparacion de quetiapina y fumarato de quetiapina
US20100178333A1 (en)	2006-01-25	2010-07-15	Astron Research Limited	Sustained release dosage form of phenothiazine derivatives containing channelizer
EP2021325A2 (en) *	2006-05-09	2009-02-11	AstraZeneca AB	Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
TWI389889B (zh) *	2006-05-09	2013-03-21	Targacept Inc	（２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
BRPI0714586A2 (pt) *	2006-07-28	2013-05-07	Farmaprojects S A	formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço
WO2008034041A2 (en) *	2006-09-15	2008-03-20	Astrazeneca Ab	Therapeutic combinations
CN101610774B (zh) *	2006-11-03	2012-04-04	萨斯喀彻温大学	治疗脱髓鞘疾病的方法
US20100028447A1 (en) *	2007-01-22	2010-02-04	Targacept, Inc.	Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
ES2352299T3 (es) *	2007-02-14	2011-02-17	Laboratorios Lesvi, S.L.	Composiciones farmacéuticas que contienen fumarato de quetiapina.
MX345970B (es) *	2008-02-27	2017-02-28	Intercontinental Great Brands Llc	Confiteria de regiones multiples.
PL2262486T3 (pl)	2008-08-01	2013-06-28	Krka Tovarna Zdravil D D Novo Mesto	Kompozycja kwetiapiny
DE102008046650A1 (de)	2008-09-10	2010-03-11	Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg	Quetiapin enthaltende Retardtablette
CN107714703A (zh)	2009-12-31	2018-02-23	凯姆制药公司	喹硫平的氨基酸缀合物、其制备和使用方法
US20110223207A1 (en)	2010-03-11	2011-09-15	Travis Mickle	Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same
SG185497A1 (en)	2010-05-20	2012-12-28	Astrazeneca Ab	New process for the preparation of aryl substituted olefinic amines
DE102010033527A1 (de)	2010-08-05	2012-02-09	Acino Pharma Ag	Quetiapin-Tabletten
DE102011115690A1 (de)	2011-10-11	2013-04-11	Acino Pharma Ag	Quetiapin enthaltende Formulierungen
US9993486B1 (en)	2017-06-19	2018-06-12	Tlc Therapeutics, Llc	Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability
JP2023524025A (ja) *	2020-04-29	2023-06-08	ステパンカンパニー	アミン、プロトン化アミン、または第四級アンモニウム化合物を含む固体組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8607684D0 (en) *	1986-03-27	1986-04-30	Ici America Inc	Thiazepine compounds
GB8705574D0 (en) *	1987-03-10	1987-04-15	Ici Plc	Preparation of thiazepine compound
EP0416773B1 (en) *	1989-08-31	1993-03-03	Takeda Chemical Industries, Ltd.	Vitamin b12 composition
IT1250701B (it) *	1991-07-24	1995-04-21	Angelini Francesco Ist Ricerca	Composizione farmaceutica solida per uso orale a base di dapiprazolo
JPH06100602A (ja) *	1992-09-18	1994-04-12	Asahi Chem Ind Co Ltd	経口固形製剤およびその製造方法
US5397576A (en) *	1992-09-23	1995-03-14	Hoffmann-La Roche Inc.	Spray triturated micronutrient compositions
ES2113081T3 (es) *	1992-11-09	1998-04-16	Knoll Ag	1,4-benzotiazepinas utiles como agentes neurologicos.
ZA973433B (en) *	1996-04-24	1997-12-10	Shionogi & Co	A sertindole-containing preparation and a method for producing the same.
US5948437A (en) *	1996-05-23	1999-09-07	Zeneca Limited	Pharmaceutical compositions using thiazepine
GB9611328D0 (en) *	1996-05-31	1996-08-07	Zeneca Ltd	Pharmaceutical compositions
WO1998013027A1 (en) *	1996-09-24	1998-04-02	Eli Lilly And Company	Coated particle formulation
US7919119B2 (en) *	1999-05-27	2011-04-05	Acusphere, Inc.	Porous drug matrices and methods of manufacture thereof
GB9922271D0 (en) *	1999-09-21	1999-11-17	Zeneca Ltd	Formulation

1999
- 1999-09-21 GB GBGB9922271.3A patent/GB9922271D0/en not_active Ceased
2000
- 2000-09-01 GB GBGB0021406.4A patent/GB0021406D0/en not_active Ceased
- 2000-09-18 CZ CZ20020974A patent/CZ301585B6/cs not_active IP Right Cessation
- 2000-09-18 NZ NZ517549A patent/NZ517549A/en not_active IP Right Cessation
- 2000-09-18 RU RU2002110456/15A patent/RU2256453C2/ru not_active IP Right Cessation
- 2000-09-18 CN CNB00813166XA patent/CN1188130C/zh not_active Expired - Lifetime
- 2000-09-18 DK DK00960855T patent/DK1218009T3/da active
- 2000-09-18 MX MXPA02002627A patent/MXPA02002627A/es active IP Right Grant
- 2000-09-18 CN CNB2004101011599A patent/CN1331472C/zh not_active Expired - Lifetime
- 2000-09-18 SI SI200030640T patent/SI1218009T1/xx unknown
- 2000-09-18 AU AU73023/00A patent/AU776292B2/en not_active Ceased
- 2000-09-18 US US10/088,804 patent/US6599897B1/en not_active Expired - Lifetime
- 2000-09-18 EE EEP200200150A patent/EE200200150A/xx unknown
- 2000-09-18 SK SK372-2002A patent/SK286884B6/sk not_active IP Right Cessation
- 2000-09-18 KR KR1020027003676A patent/KR100748823B1/ko not_active Expired - Fee Related
- 2000-09-18 PT PT00960855T patent/PT1218009E/pt unknown
- 2000-09-18 JP JP2001524605A patent/JP2003509461A/ja active Pending
- 2000-09-18 IL IL14844000A patent/IL148440A0/xx active IP Right Grant
- 2000-09-18 TR TR2002/00716T patent/TR200200716T2/xx unknown
- 2000-09-18 ES ES00960855T patent/ES2235941T3/es not_active Expired - Lifetime
- 2000-09-18 CN CNA2006101007643A patent/CN1899288A/zh active Pending
- 2000-09-18 CA CA002383131A patent/CA2383131A1/en not_active Abandoned
- 2000-09-18 UA UA2002043283A patent/UA73529C2/uk unknown
- 2000-09-18 WO PCT/GB2000/003598 patent/WO2001021179A1/en not_active Ceased
- 2000-09-18 AT AT00960855T patent/ATE288272T1/de active
- 2000-09-18 DE DE60017923T patent/DE60017923T2/de not_active Expired - Lifetime
- 2000-09-18 PL PL357369A patent/PL198824B1/pl unknown
- 2000-09-18 HU HU0203531A patent/HUP0203531A3/hu unknown
- 2000-09-18 HK HK02109363.8A patent/HK1047706B/en not_active IP Right Cessation
- 2000-09-18 EP EP00960855A patent/EP1218009B1/en not_active Expired - Lifetime
- 2000-09-18 BR BR0014107-0A patent/BR0014107A/pt not_active Application Discontinuation
- 2000-09-19 CO CO00070974A patent/CO5180585A1/es not_active Application Discontinuation
- 2000-09-19 MY MYPI20004370A patent/MY130208A/en unknown
- 2000-09-20 EG EG20001205A patent/EG24226A/xx active
- 2000-09-20 TW TW089119338A patent/TWI226832B/zh not_active IP Right Cessation
- 2000-09-21 AR ARP000104954A patent/AR032596A1/es unknown
2002
- 2002-02-27 IL IL148440A patent/IL148440A/en not_active IP Right Cessation
- 2002-02-28 ZA ZA200201709A patent/ZA200201709B/en unknown
- 2002-03-11 BG BG106509A patent/BG65469B1/bg unknown
- 2002-03-19 IS IS6308A patent/IS2139B/xx unknown
- 2002-03-20 NO NO20021394A patent/NO320908B1/no not_active IP Right Cessation
2003
- 2003-07-25 US US10/627,198 patent/US7022692B2/en not_active Expired - Fee Related
2006
- 2006-01-10 US US11/329,378 patent/US20060159768A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL357369A1 (en)	2004-07-26
US20060159768A1 (en)	2006-07-20
CN1899288A (zh)	2007-01-24
NO320908B1 (no)	2006-02-13
EP1218009B1 (en)	2005-02-02
AR032596A1 (es)	2003-11-19
UA73529C2 (uk)	2005-08-15
CA2383131A1 (en)	2001-03-29
CN1331472C (zh)	2007-08-15
ATE288272T1 (de)	2005-02-15
IS6308A (is)	2002-03-19
JP2003509461A (ja)	2003-03-11
CO5180585A1 (es)	2002-07-30
IS2139B (is)	2006-08-15
MY130208A (en)	2007-06-29
ZA200201709B (en)	2003-05-28
HK1047706B (en)	2005-06-10
RU2256453C2 (ru)	2005-07-20
DK1218009T3 (da)	2005-05-09
BR0014107A (pt)	2002-08-20
EE200200150A (et)	2003-04-15
AU776292B2 (en)	2004-09-02
HUP0203531A2 (hu)	2003-02-28
NO20021394D0 (no)	2002-03-20
BG65469B1 (bg)	2008-09-30
KR100748823B1 (ko)	2007-08-13
ES2235941T3 (es)	2005-07-16
PT1218009E (pt)	2005-05-31
TR200200716T2 (tr)	2002-06-21
CZ301585B6 (cs)	2010-04-21
SK286884B6 (sk)	2009-07-06
TWI226832B (en)	2005-01-21
HK1047706A1 (en)	2003-03-07
CZ2002974A3 (cs)	2002-06-12
HUP0203531A3 (en)	2004-12-28
IL148440A0 (en)	2002-09-12
GB0021406D0 (en)	2000-10-18
SK3722002A3 (en)	2002-07-02
SI1218009T1 (en)	2005-06-30
AU7302300A (en)	2001-04-24
KR20020033186A (ko)	2002-05-04
WO2001021179A1 (en)	2001-03-29
EG24226A (en)	2008-11-10
DE60017923T2 (de)	2006-01-12
US7022692B2 (en)	2006-04-04
US6599897B1 (en)	2003-07-29
IL148440A (en)	2007-07-04
NZ517549A (en)	2003-10-31
CN1374867A (zh)	2002-10-16
MXPA02002627A (es)	2002-07-30
PL198824B1 (pl)	2008-07-31
US20040228914A1 (en)	2004-11-18
DE60017923D1 (de)	2005-03-10
CN1626094A (zh)	2005-06-15
GB9922271D0 (en)	1999-11-17
EP1218009A1 (en)	2002-07-03
BG106509A (en)	2002-12-29
CN1188130C (zh)	2005-02-09

Publication	Publication Date	Title
DE50010505D1 (de)	2005-07-14	Gurtaufrollersystem
DE122007000064I1 (de)	2008-01-03	Erythropoietinkonjugate
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
DE50002834D1 (de)	2003-08-14	Handstempel
DE60001283D1 (de)	2003-03-06	Celluloseetherfilme
ATE357433T1 (de)	2007-04-15	4-pyrimidinyl-n-acyl-l-phenylanine
NO20021394L (no)	2002-03-20	Quetiapingranuler
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
DE60001894D1 (de)	2003-05-08	Busschienenverbindungsstruktur
DE59909346D1 (de)	2004-06-03	Zylinderkopfdichtung
DE50009570D1 (de)	2005-03-31	Wechselcorrugator
DE59910286D1 (de)	2004-09-23	Kniehebel-spannvorrichtung
DE60001649D1 (de)	2003-04-17	Ziprasidonsuspension
NO20022515L (no)	2002-05-28	Brönnpulsgiver
DE60000107D1 (de)	2002-05-08	Formschliessvorrichtung
DE50000805D1 (de)	2003-01-09	Aufsitzspanner
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
DE50012482D1 (de)	2006-05-18	Tibiamarknagel
DE60001471D1 (de)	2003-04-03	4-Hydroxyisothiazolverbindungen
DE50003660D1 (de)	2003-10-16	Diacylhydrazinderivate
DE50006013D1 (de)	2004-05-13	Anschlagpuffer
DE59906520D1 (de)	2003-09-11	Exzenterzahnradgetriebe
DE19983890T1 (de)	2002-03-07	Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de)	2003-05-08	Nahfeldoptische untersuchungsvorrichtung
DE50006759D1 (de)	2004-07-15	Piperidinalkohole

Legal Events

Date	Code	Title	Description
2017-04-24	MM1K	Lapsed by not paying the annual fees